- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05155449
Probiotic Intervention for Gut Function
November 15, 2023 updated by: Probi AB
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Effect of Probiotics on Gut Function in Healthy Chinese Adults
The effect of probiotics on gut function in healthy subjects.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xiangjun Meng, MD
- Phone Number: +86 021-53315134
- Email: xiangjunmeng@aliyun.com
Study Locations
-
-
-
Shanghai, China
- Recruiting
- Shanghai 9th People's Hospital
-
Contact:
- Xiangjun Meng, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age between 18 and 65 years
- BMI between 18.5 and 27.9 kg/m²
- Subjects having ≥ 3 bowel movements per day
- Subject not satisfied with their bowel habits
- Subject having frequent stools during more than 4 weeks
- For women: Non menopausal with the same reliable contraception since at least 3 cycles before the beginning of the study and agreeing to keep it during the entire duration of the study
- Subjects agreeing to keep their dietary and life habits unchanged throughout the study
- Good general and mental health within the opinion of the investigator
- Able and willing to participate to the study by complying with the protocol procedures as evidenced by a dated and signed ICF
Exclusion Criteria:
- Suffering IBS according to Rome IV criteria, chronic intestinal disease, immunodeficiency disorder or immunosuppressive treatment
- Clinically significant frequent constipation or diarrhea at the screening visit as judged by the Investigator
- Suffering from a severe chronic disease or GI disorders found to be inconsistent with the conduct of the study by the investigator
- Intake of antibiotics within 8 weeks prior to the start of the study
- With regular intake of probiotics within four weeks prior to V1 visit
- Under treatment or dietary supplement which could significantly affect parameter(s) followed during the study according to the investigator or stopped in a too short period before the V1 visit
- Suspected alcohol or substance abuse
- Use of medications other than contraceptives or prescribed medication after consulting with the investigator
- History of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the subject at risk if participating in the study, or influence the results or the subject´s ability to participate in the study
- With a known gluten intolerance, milk protein allergy
- With a known or suspected food allergy or intolerance or hypersensitivity to any of the study products' ingredients
- Pregnant or lactating women or intending to become pregnant within 3 months ahead
- With significant change in food habits or in physical activity in the 3 months before the V1 visit
- With a personal history of anorexia nervosa, bulimia or significant eating disorders according to the investigator
- Having a lifestyle deemed incompatible with the study according to the investigator
- Currently participating in another clinical study, has done so in the past 30 days or being in the exclusion period of a previous clinical trial
- Under legal protection (guardianship, wardship) or deprived from his/her rights following administrative or judicial decision
- Presenting a psychological or linguistic incapability to sign the informed consent or Investigator considers the subject unlikely to comply with study procedures, restrictions and requirements
- Impossible to contact in case of emergency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Probiotics
Two capsules per day for 8 weeks
|
Capsule
|
Placebo Comparator: Placebo
Two capsules per day for 8 weeks
|
Capsule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bowel movements
Time Frame: 8 weeks
|
Reduction of the number of bowel movements
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Xiangjun Meng, MD, Shanghai 9th People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 8, 2023
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
November 30, 2021
First Submitted That Met QC Criteria
November 30, 2021
First Posted (Actual)
December 13, 2021
Study Record Updates
Last Update Posted (Estimated)
November 16, 2023
Last Update Submitted That Met QC Criteria
November 15, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- PEC19132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gut Function
-
Scarborough General HospitalUnknown
-
USDA, Western Human Nutrition Research CenterRecruitingGut Microbiome | Gut Health | Yogurt Intake | Gastrointestinal Immune FunctionUnited States
-
University of ReadingDaniscoCompletedGut Microbiota | Immune Function | Bowel Function | Plasma LipidsUnited Kingdom
-
University of ReadingDaniscoCompletedGut Microbiota | Immune FunctionUnited Kingdom
-
Christopher BellRecruitingExercise Performance | Gut -Microbiota | Mitochondrial FunctionUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...CompletedMetabolic and Inflammatory Variables Post Intervention | Composition and Function of the Gut Microbiota Post InterventionBrazil
-
Northumbria UniversityEvolva SACompletedCerebral Blood Flow | Overweight and Obesity | Systemic Inflammation | Gut Microbiota | Cognitive Function and MoodUnited Kingdom
-
University of California, DavisCompletedGut Microbiome | Skin Microbiome | Gut Lipidome | Skin Lipidome | Blood LipidomeUnited States
-
Liverpool John Moores UniversityUniversity of Illinois at Chicago; Georgia Southern UniversityCompletedProbiotics | Athletes | Gut Microbiota | Aerobic Exercise | Gut Microbiome | Gastrointestinal Tract IrritationUnited Kingdom
-
University College CorkAIT Austrian Institute of Technology GmbHNot yet recruiting
Clinical Trials on Probiotics
-
Glac Biotech Co., LtdCompletedMetabolic SyndromeTaiwan
-
TCI Co., Ltd.Recruiting
-
University of Milano BicoccaCompleted
-
Arkansas Children's Hospital Research InstituteCompleted
-
Chr HansenAarhus University HospitalCompletedInfant Development | Gut MicrobiomeDenmark
-
Zealand University HospitalHolbaek Sygehus; Chr Hansen; Dept. of Microbiology, Slagelse University Hospital... and other collaboratorsCompleted
-
National Cheng-Kung University HospitalNational Science Council, TaiwanUnknownGastrointestinal Function | Intestinal Bacteria FloraTaiwan
-
Chung Shan Medical UniversityTCI Co., Ltd.Recruiting
-
Prof. Jacques SCHRENZELCompleted
-
Liverpool John Moores UniversityUniversity of Illinois at Chicago; Georgia Southern UniversityCompletedProbiotics | Athletes | Gut Microbiota | Aerobic Exercise | Gut Microbiome | Gastrointestinal Tract IrritationUnited Kingdom